Purdue team develops implantable delivery system; National Science Foundation funds hydrogels to help treat ear disorders;

> Purdue University researchers have created an implantable drug-delivery system that can be wirelessly controlled. "This method allows a very, very small dose of a drug to effectively serve as a big dose right where you need it," Professor of Applied Neuroscience Richard Borgens said. "By the time the drug diffuses from the site out into the rest of the body it is in amounts that are undetectable in the usual tests to monitor the concentration of drugs in the bloodstream." More

> ProLynx received additional funding from the U.S. National Science Foundation to fund in vivo imaging studies of its hydrogels as a means of drug delivery for therapies that treat inner ear disorders. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.